Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MoonLake Immunotherapeutics - Class A Ordinary Shares (NQ:MLTX)

10.59 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 572
Open 10.59
Bid (Size) 10.46 (200)
Ask (Size) 10.59 (600)
Prev. Close 10.59
Today's Range 10.59 - 10.59
52wk Range 5.950 - 62.75
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Levi & Korsinsky Reminds MoonLake Immunotherapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 15, 2025 - MLTX
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Levi & Korsinsky Reminds MoonLake Immunotherapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 15, 2025 - MLTX
Via TheNewswire.com
Topics Fraud Lawsuit

Performance

YTD
-80.2%
-80.2%
1 Month
+22.3%
+22.3%
3 Month
-80.0%
-80.0%
6 Month
-71.8%
-71.8%
1 Year
-77.8%
-77.8%

More News

Read More
Bragar Eagel & Squire, P.C. Reminds Investors of aTyr, Marex, Cepton, and MoonLake to Contact the Firm About their Rights in Filed Class Action Lawsuits
From Bragar Eagel & Squire
Via GlobeNewswire
Class Action Filed Against MoonLake Immunotherapeutics (MLTX) - December 15, 2025 Deadline to Join - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Class Action Filed Against MoonLake Immunotherapeutics (MLTX) - December 15, 2025 Deadline to Join - Contact Levi & Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
MLTX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
From Faruqi & Faruqi LLP
Via GlobeNewswire
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – MLTX
From The Rosen Law Firm PA
Via GlobeNewswire
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
Levi & Korsinsky Reminds MoonLake Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 15, 2025 - MLTX
Via NewMediaWire
Topics Fraud Lawsuit
Levi & Korsinsky Reminds MoonLake Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 15, 2025 - MLTX
Via TheNewswire.com
Topics Fraud Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors of aTyr, Marex, Cepton, and MoonLake to Contact the Firm About their Rights in Filed Class Action Lawsuits
From Bragar Eagel & Squire
Via GlobeNewswire
Deadline Alert: MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
From Glancy Prongay & Murray LLP
Via Business Wire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
From Faruqi & Faruqi LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in MoonLake Immunotherapeutics of Class Action Lawsuit and Upcoming Deadlines - MLTX
From Pomerantz LLP
Via GlobeNewswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in MoonLake Lawsuit - MLTX
Via NewMediaWire
Topics Fraud Lawsuit
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in MoonLake Lawsuit - MLTX
Via TheNewswire.com
Topics Fraud Lawsuit
MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Deadline Approaching: MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
From Law Offices of Howard G. Smith
Via Business Wire
Levi & Korsinsky Notifies MoonLake Immunotherapeutics Investors of a Class Action Lawsuit and Upcoming Deadline - MLTX
Via TheNewswire.com
Topics Fraud Lawsuit
Levi & Korsinsky Notifies MoonLake Immunotherapeutics Investors of a Class Action Lawsuit and Upcoming Deadline - MLTX
Via NewMediaWire
Topics Fraud Lawsuit
Law Offices of Frank R. Cruz Encourages MoonLake Immunotherapeutics (MLTX) Shareholders to Inquire About Securities Fraud Class Action
From Law Offices of Frank R. Cruz
Via Business Wire
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
Levi & Korsinsky Notifies Shareholders of MoonLake Immunotherapeutics (MLTX) of a Class Action Lawsuit and an Upcoming Deadline
Via NewMediaWire
Topics Fraud Lawsuit

Frequently Asked Questions

Is MoonLake Immunotherapeutics - Class A Ordinary Shares publicly traded?
Yes, MoonLake Immunotherapeutics - Class A Ordinary Shares is publicly traded.
What exchange does MoonLake Immunotherapeutics - Class A Ordinary Shares trade on?
MoonLake Immunotherapeutics - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for MoonLake Immunotherapeutics - Class A Ordinary Shares?
The ticker symbol for MoonLake Immunotherapeutics - Class A Ordinary Shares is MLTX on the Nasdaq Stock Market
What is the current price of MoonLake Immunotherapeutics - Class A Ordinary Shares?
The current price of MoonLake Immunotherapeutics - Class A Ordinary Shares is 10.59
When was MoonLake Immunotherapeutics - Class A Ordinary Shares last traded?
The last trade of MoonLake Immunotherapeutics - Class A Ordinary Shares was at 11/05/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.